Cancer research
Research at University Hospital Hamburg Eppendorf in Hamburg, Germany, has shed light on the current practices in staging intermediate-risk prostate cancer patients. According to the study, current European Association of Urology (EAU) guidelines provide only a weak recommendation for staging in selected intermediate-risk prostate cancer patients. However, data on the
Cancer research
Research findings from the University of Hong Kong have shed light on the significance of glycaemic control in preventing pancreatic cancer in patients with type 2 diabetes. The study, published in Gut, a peer-reviewed journal, aimed to investigate the effects of glycaemic control on pancreatic cancer development in patients with
Cancer research
Researchers at Tianjin Medical University have made a significant breakthrough in the treatment of liver cancer by developing biomimetic nanoparticles that target and eliminate cancer cells while promoting antitumor immunity. According to a recent study, the nanoparticles, known as CP@HMM, have shown promise in enhancing extracellular ATP homeostasis, driving
Cancer research
Researchers at Nanjing University of Chinese Medicine have made a significant breakthrough in the treatment of liver cancer using a novel delivery system. The Astragaloside II (ASII)-loaded neutrophil nanocarrier system, known as PG@AS-Neu, has been shown to exhibit potent anticancer effects while maintaining the integrity of the cancer-fighting
Cancer research
A new study published in the Journal of Heart Rhythm has revealed that early-onset atrial fibrillation (AF) in patients without underlying cardiovascular conditions is associated with a significantly increased risk of long-term cardiovascular complications, including heart failure, stroke, and mortality. The research, conducted by a team of scientists at Copenhagen
Cancer research
Researchers have made significant progress in understanding the properties and potential applications of alantolactone (ATL), a bioactive sesquiterpene lactone. Derived from medicinal plants, ATL exhibits anti-cancer and anti-inflammatory properties, making it a promising candidate for cancer treatment. However, its clinical application is limited by its inadequate solubility in water and
Cancer research
Researchers at the Yale University School of Medicine have made a significant breakthrough in understanding the role of asparagine-linked glycosylation protein 1 (ALG1) in lung cancer progression. According to a newly published study, ALG1 promotes aggressive phenotypes of lung adenocarcinoma cells by modulating N-linked glycosylation and endoplasmic reticulum (ER)-stress
Cancer research
Research conducted at the Gansu University of Chinese Medicine in People's Republic of China has led to a potential breakthrough in the treatment of non-small cell lung cancer (NSCLC). The study, published in the journal Frontiers in Oncology, investigates the benefits and risks of combining Fuzheng Yiliu Decoction,
Cancer research
A new study by researchers at the Iran University of Medical Sciences has highlighted the urgent need for financial protection strategies for patients with cancer or special diseases in health systems. The research, published in Health Research Policy and Systems, aimed to identify existing strategies for financial protection for patients
Cancer research
A recent study published in Scientific Reports has identified several predictive factors for unplanned acute care (UAC) in outpatients receiving oral anticancer drugs. The research, conducted at the National Cancer Center Hospital East in Chiba, Japan, aimed to identify factors associated with increased risk of UAC, which can lead to
Cancer research
Research conducted by scientists at Bengbu Medical University has shed new light on the role of long non-coding RNA (lncRNA) FEZF1-AS1 in non-small cell lung cancer (NSCLC) tumorigenesis and ferroptosis. The study found that FEZF1-AS1 promotes NSCLC progression through suppressing ferroptosis by activating the tumor necrosis factor-alpha (TNF-a)/nuclear factor-kappa
Cancer research
Research at University Hospital Hamburg Eppendorf in Hamburg, Germany, has shed light on the current practices in staging intermediate-risk prostate cancer patients. According to the study, current European Association of Urology (EAU) guidelines provide only a weak recommendation for staging in selected intermediate-risk prostate cancer patients. However, data on the
